Author
A. J. Spencer
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2021 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 43 mutual co-author links5 papers
Recent·Most cited
- DOI 10.1016/j.ebiom.2022.103902
- ImmunologybioRxiv
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice
A. J. Spencer, P. F. McKay, S. Belij-Rammerstorfer…·T. Lambe
This study shows that heterologous vaccination with self-amplifying RNA and adenoviral SARS-CoV-2 vaccines in mice produces stronger antibody and cellular immune responses than single-dose regimens.
DOI 10.1038/s41467-021-23173-1 - ImmunologybioRxiv
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice
A. Silva-Cayetano, W. S. Foster, S. Innocentin…·M. A. Linterman
This study shows that a booster dose of the ChAdOx1 nCoV-19 vaccine increases immune response in aged mice compared to a single dose.
DOI 10.1016/j.medj.2020.12.006 - ImmunologybioRxivPreprint
Antigen-specific competitive inhibition of CD4+ T cell recruitment into the primary immune response
A. J. Spencer, A. L. Smith, B. Fazekas de St Groth
The paper investigates how antigen availability and timing affect CD4+ T cell recruitment and response size during the primary immune response.
DOI 10.1101/2020.08.31.276527 - ImmunologybioRxiv
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
S. P. Graham, R. K. McLean, A. J. Spencer…·T. Lambe
This study evaluates the immunogenicity of single and booster doses of the ChAdOx1 nCoV-19 vaccine in mice and pigs, finding that a booster significantly enhances antibody responses, especially in pigs.
DOI 10.1038/s41541-020-00221-3